5-(4-Bromophenyl)-4-chlorothieno[2,3-d]pyrimidine, 97%, 250mg

4-NITRO-2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE, 95%, 100mg

N-(4-Methoxybenzyl)aniline, 95.0%, 25g

Ethyl-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-amine, 98%, 1g

H-Tyr(Bzl)-OBzl.HCl, 95%, 25g

PHTHALOYL DICHLORIDE, 95.0%, 25g

Hidroxiamantanona, mínimo 98 %, para síntesis, 5 g, envase de vidrio

2-Chloro-n-{1-[(2-chlorophenyl)methyl]-1h-pyrazol-5-yl}acetamide, 97%, 250mg

(2S,4R)-1-((Benzyloxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 98%, 5g

1-Methylpiperidine-3-carboxylic acid hydrochloride, 98.0%, 1g

Naphthalene-1,4-dithiocarboxamide, 250mg

[3-(2-aminoethyl)-1,2,4-oxadiazol-5-yl]methanol hydrochloride, 95.0%, 250mg

Ethyl 6-aminopyridazine-3-carboxylate, 95.0%, 10g